Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers
about
Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trialPharmacokinetic interactions between ritonavir and quinine in healthy volunteers following concurrent administrationInterspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.Carboxymefloquine, the major metabolite of the antimalarial drug mefloquine, induces drug-metabolizing enzyme and transporter expression by activation of pregnane X receptor.HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 studyEffect of widely used combinations of antiretroviral therapy on liver CYP3A4 activity in HIV-infected patients.Malaria and hiv in adults: when the parasite runs into the virus.Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adultsPharmacotherapy, vaccines and malaria advice for HIV-infected travellers.Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infectionThe role of cytochrome P450 in antiretroviral drug interactions.Induction effects of ritonavir: implications for drug interactions.Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy.A high performance liquid chromatographic assay of mefloquine in saliva after a single oral dose in healthy adult Africans.In vivo effect of I'm-Yunity on hepatic cytochrome P450 3A4.Mefloquine for preventing malaria during travel to endemic areas.Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy
P2860
Q28543154-88E35788-CADD-4F4E-93B3-0192109CAC42Q33692808-511C3C14-0C99-42E4-BEF7-802C4D0D56D3Q34299078-F6858638-A0E6-4753-9FCA-D820ED4950D7Q34921957-6C26C846-222D-400A-BCE1-9DCC6AA63C28Q35689395-5117E13D-448A-4432-965E-ADFDCC062C8AQ35827661-F08332E4-9EDF-4095-BCCA-9AD4A62A88A5Q36033898-39100C35-83DF-4030-9E2E-2E0F91AB7886Q36144257-F8DC0761-46CA-45F1-9726-95BB02C9BC4EQ36161252-00757BC0-3D3B-4F0E-AD64-C8A19D767761Q36320042-EE26F482-126F-4F84-A58B-1B8B1B106E3DQ36909336-40717FBA-0B7F-4FF1-AC16-8B30FEDA42D8Q37199533-AAF8D58E-F923-412C-8504-825C10D9BF1AQ37863203-837E6704-54CC-4DE4-A81F-477522DEC308Q41839958-77A3BBD0-EE42-4C8B-885F-DBD2FE56BE67Q46181375-47A3C562-6B5D-4D9B-843A-7736C87D4C81Q47140318-1FECB53C-F9B9-4A4B-8B49-CD6EBFC02BBEQ57287116-41F2F9AE-1835-4924-A197-039525BF9EE9
P2860
Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers
@ast
Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers
@en
Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers
@nl
type
label
Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers
@ast
Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers
@en
Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers
@nl
prefLabel
Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers
@ast
Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers
@en
Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers
@nl
P2093
P2860
P1476
Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers
@en
P2093
P2860
P304
P356
10.1046/J.1365-2125.2001.01393.X
P407
P577
2001-06-01T00:00:00Z